Lexicon Pharma (LXRX) Tops Q3 EPS by 14c
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.42 +3.42%
Financial Fact:
Interest expense: -1.65M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Interest expense: -1.65M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q3 EPS of ($0.35), $0.14 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $27.7 million versus the consensus estimate of $9.68 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Halozyme adds biotech executive Appelhans to its board
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
